Search Results - "Klotz, L"

Refine Results
  1. 1

    Posttranscriptional regulation of FOXO expression: microRNAs and beyond by Urbánek, P, Klotz, L‐O

    Published in British journal of pharmacology (01-06-2017)
    “…Forkhead box, class O (FOXO) transcription factors are major regulators of diverse cellular processes, including fuel metabolism, oxidative stress response and…”
    Get full text
    Journal Article
  2. 2

    Activities and Effects of Ergot Alkaloids on Livestock Physiology and Production by Klotz, James L

    Published in Toxins (27-07-2015)
    “…Consumption of feedstuffs contaminated with ergot alkaloids has a broad impact on many different physiological mechanisms that alters the homeostasis of…”
    Get full text
    Journal Article Book Review
  3. 3

    Global Impact of Ergot Alkaloids by Klotz, James L

    Published in Toxins (03-03-2022)
    “…For many years, ergot alkaloids have been considered both a problem to be mitigated and a potential medical cure [...]…”
    Get full text
    Journal Article
  4. 4

    Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress by Manolopoulos, K N, Klotz, L-O, Korsten, P, Bornstein, S R, Barthel, A

    Published in Molecular psychiatry (01-11-2010)
    “…Oxidative stress is an important determinant not only in the pathogenesis of Alzheimer's disease (AD), but also in insulin resistance (InsRes) and diabetic…”
    Get full text
    Journal Article
  5. 5

    The endocannabinoid system in bovine tissues: characterization of transcript abundance in the growing Holstein steer by Kent-Dennis, Coral, Klotz, James L

    Published in BMC veterinary research (22-10-2024)
    “…The endocannabinoid system (ECS) is highly integrated with seemingly all physiological and pathophysiological processes in the body. There is increasing…”
    Get full text
    Journal Article
  6. 6

    Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events by Smith, M.R., Coleman, R.E., Klotz, L., Pittman, K., Milecki, P., Ng, S., Chi, K.N., Balakumaran, A., Wei, R., Wang, H., Braun, A., Fizazi, K.

    Published in Annals of oncology (01-02-2015)
    “…In this analysis of a phase III trial in patients with castration-resistant prostate cancer and bone metastases, treatment with denosumab reduced the risk of…”
    Get full text
    Journal Article
  7. 7

    Active surveillance for intermediate-risk prostate cancer by Dall'Era, M A, Klotz, L

    Published in Prostate cancer and prostatic diseases (01-03-2017)
    “…Background: Utilization of active surveillance (AS) for prostate cancer is increasing. Optimal selection criteria for this approach are undefined and questions…”
    Get full text
    Journal Article
  8. 8

    Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis by Eichhorn, F., Klotz, L.V., Muley, T., Kobinger, S., Winter, H., Eichhorn, M.E.

    Published in Lung cancer (Amsterdam, Netherlands) (01-12-2019)
    “…•Nodal positive (N1) NSCLC population can be split towards different prognostic subgroups.•Increased nodal burden (pN1b, multiple zone involvement) is…”
    Get full text
    Journal Article
  9. 9

    Isoflavone supplementation, via red clover hay, alters the rumen microbial community and promotes weight gain of steers grazing mixed grass pastures by Harlow, Brittany E, Flythe, Michael D, Kagan, Isabelle A, Goodman, Jack P, Klotz, James L, Aiken, Glen E

    Published in PloS one (13-03-2020)
    “…Biochanin A, an isoflavone present in the pasture legume red clover (Trifloium pratense L.), alters fermentation in the rumen of cattle and other ruminants…”
    Get full text
    Journal Article
  10. 10

    Metformin and prostate cancer stem cells: a novel therapeutic target by Mayer, M J, Klotz, L H, Venkateswaran, V

    Published in Prostate cancer and prostatic diseases (01-12-2015)
    “…Prostate cancer is the second most frequently diagnosed cancer in the world. Localized disease can be effectively treated with radiation therapy or radical…”
    Get full text
    Journal Article
  11. 11

    Immunomodulation by cannabidiol in bovine primary ruminal epithelial cells by Kent-Dennis, C, Klotz, James L

    Published in BMC veterinary research (16-10-2023)
    “…Abstract Background Ruminant livestock experience a number of challenges, including high concentrate diets, weaning and transport, which can increase their…”
    Get full text
    Journal Article
  12. 12

    Influence of postruminal casein infusion and exogenous glucagon-like peptide 2 administration on the jejunal mucosal transcriptome in cattle by Trotta, Ronald J, Swanson, Kendall C, Klotz, James L, Harmon, David L

    Published in PloS one (15-08-2024)
    “…We previously demonstrated that postruminal casein infusion and exogenous glucagon-like peptide 2 (GLP-2) administration independently stimulated growth and…”
    Get full text
    Journal Article
  13. 13

    Effect of biochanin A on the rumen microbial community of Holstein steers consuming a high fiber diet and subjected to a subacute acidosis challenge by Harlow, Brittany E, Flythe, Michael D, Klotz, James L, Harmon, David L, Aiken, Glen E

    Published in PloS one (21-07-2021)
    “…Subacute rumen acidosis (SARA) occurs when highly fermentable carbohydrates are introduced into the diet, decreasing pH and disturbing the microbial ecology of…”
    Get full text
    Journal Article
  14. 14

    High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis by Samadzadeh, S, Havla, J, Lepka, K, Brinks, R, Meuth, S G, Klotz, L, Albrecht, P

    Published in Frontiers in immunology (2024)
    “…Economic and health care restraints strongly impact on drug prescription for chronic diseases. We aimed to identify potential factors for prescription behavior…”
    Get full text
    Journal Article
  15. 15

    Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer by NAM, R. K, SUGAR, L, TRACHTENBERG, J, NAROD, S. A, SETH, A, YANG, W, SRIVASTAVA, S, KLOTZ, L. H, YANG, L-Y, STANIMIROVIC, A, ENCIOIU, E, NEILL, M, LOBLAW, D. A

    Published in British journal of cancer (17-12-2007)
    “…The prostate-specific gene, TMPRSS2 is fused with the gene for the transcription factor ERG in a large proportion of human prostate cancers. The prognostic…”
    Get full text
    Journal Article
  16. 16

    Active surveillance for prostate cancer: patient selection and management by Klotz, L

    Published in Current oncology (Toronto) (01-09-2010)
    “…Screening for prostate cancer using prostate-specific antigen (PSA) has been appealing. However, the significant associated decline in prostate cancer…”
    Get full text
    Journal Article
  17. 17

    Serotonin receptor‐mediated vasorelaxation occurs primarily through 5‐HT4 activation in bovine lateral saphenous vein by Trotta, Ronald J., Harmon, David L., Klotz, James L.

    Published in Physiological reports (01-07-2024)
    “…To better understand mechanisms of serotonin‐ (5‐HT) mediated vasorelaxation, isolated lateral saphenous veins from cattle were assessed for vasoactivity using…”
    Get full text
    Journal Article
  18. 18

    Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project by Tay, K J, Scheltema, M J, Ahmed, H U, Barret, E, Coleman, J A, Dominguez-Escrig, J, Ghai, S, Huang, J, Jones, J S, Klotz, L H, Robertson, C N, Sanchez-Salas, R, Scionti, S, Sivaraman, A, de la Rosette, J, Polascik, T J

    Published in Prostate cancer and prostatic diseases (01-09-2017)
    “…Background: Whole-gland extirpation or irradiation is considered the gold standard for curative oncological treatment for localized prostate cancer, but is…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Active Surveillance with Selective Delayed Intervention Using PSA Doubling Time for Good Risk Prostate Cancer by Klotz, Laurence

    Published in European urology (2005)
    “…Good risk prostate cancer, defined as patients with a Gleason score of 6 or less, PSA <10–15, and T1c–T2a, now constitutes 50% of newly diagnosed prostate…”
    Get full text
    Journal Article
  20. 20

    Influence of Prolonged Serotonin and Ergovaline Pre-Exposure on Vasoconstriction Ex Vivo by Valente, Eriton E L, Harmon, David L, Klotz, James L

    Published in Toxins (23-12-2021)
    “…Ergot alkaloid mycotoxins interfere in many functions associated with serotonergic neurotransmitters. Therefore, the objective was to evaluate whether the…”
    Get full text
    Journal Article